Blockade of IL-6R prevents preterm birth and adverse neonatal outcomes

Winters, Andrew D.; Berkowitz, Bruce A.; Podolsky, Robert H.; Shen, Yimin; Panaitescu, Bogdan; Glazier, Catherine R.

Abstract

Background: Preterm birth preceded by spontaneous preterm labour often occurs in the clinical setting of sterile intra-amniotic inflammation (SIAI), a condition that currently lacks treatment. Methods: Proteomic and scRNA-seq human data were analysed to evaluate the role of IL-6 and IL-1? in SIAI. A C57BL/6 murine model of SIAI-induced preterm birth was developed by the ultrasound-guided intra-amniotic injection of IL-1?. The blockade of IL-6R by using an aIL-6R was tested as prenatal treatment for preterm birth and adverse neonatal outcomes. QUEST-MRI evaluated brain oxidative stress in utero. Targeted transcriptomic profiling assessed maternal, foetal, and neonatal inflammation. Neonatal biometrics and neurodevelopment were tested. The neonatal gut immune-microbiome was evaluated using metagenomic sequencing and immunophenotyping. Findings: IL-6 plays a critical role in the human intra-amniotic inflammatory response, which is associated with elevated concentrations of the alarmin IL-1?. Intra-amniotic injection of IL-1? resembles SIAI, inducing preterm birth (7% vs. 50%, p = 0.03, Fisher's exact test) and neonatal mortality (18% vs. 56%, p = 0.02, Mann–Whitney U-test). QUEST-MRI revealed no foetal brain oxidative stress upon in utero IL-1? exposure (p > 0.05, mixed linear model). Prenatal treatment with aIL-6R abrogated IL-1?-induced preterm birth (50% vs. 7%, p = 0.03, Fisher's exact test) by dampening inflammatory processes associated with the common pathway of labour. Importantly, aIL-6R reduces neonatal mortality (56% vs. 22%, p = 0.03, Mann–Whitney U-test) by crossing from the mother to the amniotic cavity, dampening foetal organ inflammation and improving growth. Beneficial effects of prenatal IL-6R blockade carried over to neonatal life, improving survival, growth, neurodevelopment, and gut immune homeostasis. Interpretation: IL-6R blockade can serve as a strategy to treat SIAI, preventing preterm birth and adverse neonatal outcomes. Funding: NICHD/NIH/DHHS, Contract HHSN275201300006C. WSU Perinatal Initiative in Maternal, Perinatal and Child Health. © 2023

Más información

Título según WOS: ID WOS:001110459700001 Not found in local WOS DB
Título según SCOPUS: Blockade of IL-6R prevents preterm birth and adverse neonatal outcomes
Título de la Revista: eBioMedicine
Volumen: 98
Editorial: Elsevier B.V.
Fecha de publicación: 2023
Idioma: English
DOI:

10.1016/j.ebiom.2023.104865

Notas: ISI, SCOPUS